76 reports

ICR conducts research services in areas of breast cancer, clinical studies, molecular pathology, genetics and epidemiology, radiotherapy and imaging, among others.

  • Pathology
  • Pharmaceutical
  • United Kingdom
  • Deals & Alliance
  • CellCentric Ltd
  • AMA-0825 - DRUG PROFILE

Rho Associated Protein Kinase ## (Renal Carcinoma Antigen NY REN ## or Rho Associated Coiled Coil Containing Protein Kinase ## or p## ROCK ## or ROCK## or EC ##. ##. ##. ##) - Overview Rho-Associated Protein Kinase ## (ROCK##) is a protein serine/ threonine kinase.

  • Pathology
  • Pharmaceutical
  • Specialty Hospital
  • United Kingdom
  • Product Initiative
  • Nov 22, 2017: New project will investigate the complexity of cancer

Sequencing a human genome means finding the sequence of someone' s unique ##. ## billion letters of DNA one-by-one.

  • Cancer
  • Pathology
  • Therapy
  • United Kingdom
  • Deals & Alliance

GlobalData Cytox Ltd' s, deal volume increased from zero medical equipment deals in 2016 to one medical equipment deal in 2017.

  • Medical Device
  • Pathology
  • United Kingdom
  • Deals & Alliance
  • Cytox Limited
  • MAR 23, 2018: BREAST CANCER: NEW MECHANISM DISCOVERED FOR DISSEMINATION OF METASTATIC TUMOUR CELLS
  • GOVERNMENT AND PUBLIC INTEREST

The organization works in collaboration with the Research Institute of Molecular Pathology, Boehringer' s basic research center.

  • Healthcare
  • Medical Biotechnology
  • Pathology
  • Austria
  • United Kingdom

GlobalData University of Southampton, reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Pathology
  • Pharmaceutical
  • Therapy
  • United Kingdom
  • BioInvent
  • DEC 14, 2017: GROUNDBREAKING GENE THERAPY TRIAL SET TO CURE HEMOPHILIA

" The Horizon 2020 research grant is one of the most prestigious grants in Europe.

  • Healthcare
  • Pathology
  • Pharmaceutical
  • Austria
  • United Kingdom
  • FEATURED NEWS & PRESS RELEASES

Future treatment of human disease will increasingly move from a ' one size fits all' approach to one of tailoring the treatment to the individual patient.

  • Asthma
  • Pathology
  • Therapy
  • Austria
  • United Kingdom

The molecules developed by Companies in Phase II and Preclinical stages are ## and ## respectively.

  • Pathology
  • Therapy
  • United Kingdom
  • Product Initiative
  • Xention Limited

DEAL IN BRIEF Partner ## Partner ## Deal status Deal category Deal sub-category Date of announcement Company type Stock exchange Ticker symbol Business description PARTNER ##: PFIZER INC.

  • Healthcare
  • Pathology
  • Pharmaceutical
  • Therapy
  • United Kingdom

The Forma / Oxford collaboration brings together expertise in disease molecular pathology and DUB biology from University teams, including the Alzheimer' s Research UK Oxford Drug Discovery Institute (ODDI) and the Oxford Parkinson' s Disease Centre (OPDC), and FORMA' s deep

  • Healthcare
  • Pathology
  • Pharmaceutical
  • Therapy
  • United Kingdom

Its mission is to discover and develop effective therapies against cancer identification and validation of molecular targets involved in cancer pathologies.

  • Healthcare
  • Pathology
  • Pharmaceutical
  • Therapy
  • United Kingdom

Its mission is to discover and develop effective therapies against cancer identification and validation of molecular targets involved in cancer pathologies.

  • Healthcare
  • Pathology
  • Pharmaceutical
  • Therapy
  • United Kingdom

First, XmAb## sequesters free IgE and prevents activation of mast cells and basophils, the mediators of allergic inflammation and pathology.

  • Autoimmune Disease
  • Medical Biotechnology
  • Pathology
  • United Kingdom
  • Product Initiative
  • Small Molecule to Target GPCR for CNS Disorders

It is a GLP-## antagonist.

  • Pathology
  • Therapy
  • United Kingdom
  • Company Operations
  • Heptares Therapeutics Limited

Company type Business description Industry Chiesi Farmaceutici S. p. A. is a pharmaceutical company engaged in research and development activities focused on respiratory pathologies.

  • Drug Development
  • Healthcare
  • Pathology
  • Pharmaceutical
  • United Kingdom